NEIL KUMAR - 16 Feb 2022 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
CEO and President, Director
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
16 Feb 2022
Net transactions value
-$27,271
Form type
4
Filing time
18 Feb 2022, 15:35:29 UTC
Previous filing
07 Dec 2021
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +7,524 +0.16% 4,730,328 16 Feb 2022 Direct F1
transaction BBIO Common Stock Tax liability $27,271 -3,085 -0.07% $8.84 4,727,243 16 Feb 2022 Direct F2
holding BBIO Common Stock 1,612,722 16 Feb 2022 See Footnote F3
holding BBIO Common Stock 1,195,686 16 Feb 2022 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -5,130 -10% $0.000000 46,164 16 Feb 2022 Common Stock 5,130 Direct F1, F5
transaction BBIO Restricted Stock Units Options Exercise $0 -2,394 -7.7% $0.000000 28,730 16 Feb 2022 Common Stock 2,394 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 7,524 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4 The shares are held by Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F5 The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F6 The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.

Remarks:

Title: Secretary, Treasurer and Chief Financial Officer